Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gastric Cancer
Related studies linked through entity extraction aliases.
Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
- Status
- COMPLETED
- Phase
- PHASE3
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Avastin and Taxotere for Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2